The study of human pluripotent stem cells, which can develop into any cell type in the body, is providing Weill Cornell Medicine and NewYork-Presbyterian investigators with new insights into the virus that causes COVID-19 and how it may infect organs such as the pancreas and liver.
A new technology developed by Weill Cornell Medicine and Max Planck Institute for Medical Research scientists allows the controlled, on-and-off “switching” of neural receptors with unprecedented efficiency and precision.
An enzyme found in brain cells can break apart the precursors to plaques that accumulate in the organ and cause toxicity in Alzheimer’s disease, according to a new study led by Weill Cornell Medicine scientists.
Dr. Ghazaleh Ashrafi, a postdoctoral associate in biochemistry at Weill Cornell Medicine, has won a 2017 Tri-Institutional Breakout Award for Junior Investigators.
The Tri-Institutional Therapeutics Discovery Institute is speeding early-stage drug development through an innovative collaboration between academia and industry.
Weill Cornell Medical College and drug maker UCB have teamed up to translate innovative Weill Cornell-led research in bone disorders, metabolic disease and genetics into next-generation treatments.
Researchers at Weill Cornell Medical College have unlocked the structure of a key protein that, when sensing certain viruses and bacteria, triggers the body's immediate immune response.
Luminescent Firefly Protein Used to Study How the Brain Is Fueled NEW YORK (Aug. 9, 2010) — Dr. Timothy Ryan has been selected as one of four scientists to receive the prestigious 2010 McKnight Technological Innovations in Neuroscience Award. The...
The Rab10 Protein Helps Regulate the Uptake of Glucose Into Cells, According to Weill Cornell Medical College Study NEW YORK (April 3, 2007) — Scientists at Weill Cornell Medical College have identified a protein called Rab10 as an important partner...
$2.8 Million Grant Will Further Research into Cellular Transport, with Potential Applications for Wide Range of Diseases NEW YORK (April 14, 2006) — Renowned for his breakthrough discoveries in intracellular trafficking, Weill Medical College of Cornell University biochemist Dr. Frederick...
Dr. Hugh Robertson, 1943-2005 Dr. Hugh Robertson, professor of biochemistry and respected colleague and friend of Weill Cornell Medical College, died on August 22 at the age of 62. Dr. Robertson was a distinguished faculty member and widely known...
Inhibitor Is Engineered That Prevents Nerve Cell Death in Laboratory-Grown Cells Data Suggest Potential Target for Alzheimer's Disease Treatments New York, NY (April 16, 2004) — Researchers from Weill Cornell Medical College and Columbia University College of Physicians & Surgeons...
A $1.5 million grant from the W.M. Keck Foundation has established a new research and training programcalled Cellular and Molecular Biophysics of Signal Transductionto be conducted jointly by Weill Medical College and Cornell University in Ithaca. Through this new...
